# Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

> **NCT03096275** · PHASE3 · COMPLETED · sponsor: **Chinese SLE Treatment And Research Group** · enrollment: 138 (actual)

## Conditions studied

- Takayasu Arteritis

## Interventions

- **DRUG:** MMF
- **DRUG:** CYC
- **DRUG:** Glucocorticoids
- **DRUG:** MTX
- **DRUG:** AZA

## Key facts

- **NCT ID:** NCT03096275
- **Lead sponsor:** Chinese SLE Treatment And Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-16
- **Primary completion:** 2022-11-11
- **Final completion:** 2022-11-11
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03096275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03096275, "Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03096275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*